GALZA MET 50MG 850MG TAB 14s

Galza Met 50mg/850mg Tablet (14s):

Galza Met 50mg/850mg Tablet 14s – Dual Action Diabetes Control

Galza Met 50mg/850mg Tablet is a combination of Vildagliptin (50mg) and Metformin (850mg), used for the effective management of Type 2 Diabetes Mellitus. This oral antidiabetic medication works by improving insulin sensitivity, reducing glucose production, and enhancing insulin secretion in response to meals.

Vildagliptin is a DPP-4 inhibitor that increases incretin levels, improving pancreatic beta-cell function, while Metformin is a biguanide that reduces hepatic glucose output and improves peripheral glucose uptake.

✅ Key Benefits:

• Effective blood sugar control for Type 2 Diabetes

• Dual mechanism improves insulin action and glucose regulation

• Reduces fasting and postprandial blood sugar levels

• Helps prevent diabetes-related complications

• Supports weight-neutral diabetes management

💊 Active Ingredients:

• Vildagliptin 50mg – DPP-4 Inhibitor

• Metformin 850mg – Biguanide

📋 Indications:

• Type 2 Diabetes Mellitus

• In patients uncontrolled with Metformin monotherapy

• As an adjunct to diet and exercise

📦 Product Details:

• Pack Size: 14 Tablets

• Strength: 50mg Vildagliptin + 850mg Metformin

• Form: Oral tablet

• Route: Oral

• Prescription Required

• Manufacturer: [Insert manufacturer name, e.g., Getz Pharma or relevant brand]

⚠️ Precautions & Side Effects:

• Common: Nausea, diarrhea, headache, low blood sugar (hypoglycemia)

• Rare but serious: Lactic acidosis (with Metformin)

• Regular monitoring of blood glucose and kidney function recommended

• Not for use in Type 1 Diabetes or Diabetic Ketoacidosis